AEHR TEST SYSTEMS·4

Apr 20, 4:56 PM ET

POSEDEL RHEA J 4

4 · AEHR TEST SYSTEMS · Filed Apr 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Aehr Test Systems Director Rhea J. Posedel Sells 7,500 Shares

What Happened

Rhea J. Posedel, a director of Aehr Test Systems (AEHR), sold 7,500 shares on April 20, 2026. The shares were disposed at $88.09 per share for a total proceeds of approximately $660,675. This was a sale (not a purchase), which is generally considered routine insider selling and not by itself a signal of company prospects.

Key Details

  • Transaction date: April 20, 2026
  • Transaction type/code: Sale (S) — reported as open-market or private sale
  • Shares sold: 7,500 at $88.09 each; total value ≈ $660,675
  • Shares owned after transaction: Not disclosed in the provided filing
  • Footnote: F1 — the amount reported includes shares subject to unvested restricted stock units (RSUs)
  • Filing timeliness: Report filed the same day (period of report 2026-04-20), so appears timely
  • No 10b5-1 plan, tax-withholding, or other special codes were noted in the provided details

Context

Sales by directors can be routine (diversification, tax planning, liquidity) and do not necessarily indicate a change in view about the company. The filing notes inclusion of shares subject to unvested RSUs in the reported amounts; this can affect how many shares remain subject to vesting rules but does not change that the reported transaction was a disposal of 7,500 shares.

Insider Transaction Report

Form 4
Period: 2026-04-20
Transactions
  • Sale

    Common Stock

    2026-04-20$88.09/sh7,500$660,675396,979 total(indirect: By Trust)
Holdings
  • Common Stock

    [F1]
    71,163
Footnotes (1)
  • [F1]The amount reported includes shares subject to unvested restricted stock units.
Signature
/s/Chris Siu, Attorney-in-Fact|2026-04-20

Documents

2 files